In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
- InMed does not grow cannabis. We biosynthesize the compounds in a lab.
- InMed products do not contain THC.
- InMed products are applied topically.
In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
A peer-reviewed scientific study entitled “Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway” has been published in the International
InMed’s CEO, Mr. Eric A. Adams, presents at the Emerging Growth Conference. This virtual presentation was given on March 8th, 2023. In the presentation, Mr.
InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, shares results from early neurodegenerative disease studies demonstrating how specific cannabinoids induced neuroprotective effects and
© Copyright 2023 InMed Pharmaceuticals Inc.
"*" indicates required fields